Luly Jay R. - Insider Non-Derivative Transactions at ENANTA PHARMACEUTICALS INC (ENTA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 12, 2024, Luly Jay R.'s relationship to ENANTA PHARMACEUTICALS INC (ENTA) is Director,Officer (President and CEO), and currently has 812,193 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ENTA insiders.
Data Source: SEC.
Luly Jay R. - Insider Non-Derivative Transactions of ENTA Common Stock
Luly Jay R. - Insider Non-Derivative Transactions at ENTA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 13, 2024 | F -- (Common Stock) | 1584 | 12.41 | 810609 |
| Feb 13, 2024 | Acquisition -- (Common Stock) | 5400 | 0 | 812193 |
| Dec 6, 2023 | Sell -- (Common Stock) | 7230 | 9.63 | 806793 |
| Dec 2, 2023 | F -- (Common Stock) | 5787 | 9.49 | 814023 |
| Mar 14, 2023 | Sell -- (Common Stock) | 1566 | 46.13 | 819810 |
| Mar 14, 2023 | Sell -- (Common Stock) | 15649 | 45.31 | 821376 |
| Mar 14, 2023 | Sell -- (Common Stock) | 10697 | 44.81 | 837025 |
| Mar 14, 2023 | M -- (Common Stock) | 27912 | 14 | 847722 |
| Feb 14, 2023 | F -- (Common Stock) | 20591 | 52.77 | 799219 |
| Feb 14, 2023 | Acquisition -- (Common Stock) | 15285 | 0 | 803590 |
| Feb 14, 2023 | Acquisition -- (Common Stock) | 22950 | 0 | 811255 |
| Feb 14, 2023 | F -- (Common Stock) | 20591 | 52.77 | 819810 |
| Feb 14, 2023 | Acquisition -- (Common Stock) | 16220 | 0 | 819810 |
| Feb 14, 2023 | Acquisition -- (Common Stock) | 29146 | 0 | 840401 |